Substance
ID:449676
Names and Identifiers
IUPAC name
(1-hydroxy-1-phosphonoethyl)phosphonic acid
Synonyms
EtidronateKsidifonEtidronateXidiphone
IUPAC Traditional name
(1-hydroxy-1-phosphonoethyl)phosphonic acid
Registration numbers
CAS Number
Properties
Pharmacology Properties
Mechanism of Action
Bone resorption inhibitor
Reduces the number of osteoclasts in active bone turnover-sites
Chelator
Product Information
Application(s)
This medicine is used to treat Paget's Disease, and to treat conditions of irregular bone growth due to hip fracture or spinal cord injury
Molecule Details
No Data Available
Click here to submit data
Molecular Spectra
No Data Available
Click here to submit data
References
• Rizhalla, E.N. et al., Talanta, 1980, 27, 715, (complexes)
• Perfil'ev, V.A. et al., Zh. Anal. Khim., 1984, 39, 2133, (detn, V)
• Fleisch, H., Bisphosphonates and Tumor Osteolysis, (Brunner, K.W. et al, ed.), Springer-Verlag, Berlin, 1989, 1, (rev)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, DXD400; TEE250; TNL750; HKS780
• Michael, W.R. et al., Toxicol. Appl. Pharmacol., 1972, 21, 503, (metab)
• Collins, A.J. et al., J. Appl. Chem. Biotechnol., 1977, 27, 651, (props, salts)
• Worms, K.H. et al., Z. Anorg. Allg. Chem., 1979, 457, 209, (synth)
• Fonong, T. et al., Anal. Chem., 1983, 55, 1089, (props)
• Encyclopedia of Food and Color Additives, (ed. Burdock, G.A.), CRC Press, 1997, 1371-1372
• Shkol'nikova, L.M. et al., Kristallografiya, 1991, 36, 77; Sov. Phys. Crystallogr. (Engl. Transl.), 1991, 36, 40, (cryst structs)
• Osvath, R., Food Chem. News, 2001, 43(32), 11, (use)
• Kasparek, F., Monatsh. Chem., 1968, 99, 2016, (synth)
• Kashina, N.A. et al., Zh. Obshch. Khim., 1992, 62, 1567; J. Gen. Chem. USSR (Engl. Transl.), 1992, 62, 1284, (props)
• Pribil, R. et al., Talanta, 1967, 14, 591, (use)
• Bikhman, B.I. et al., Zh. Neorg. Khim., 1973, 18, 2406; Russ. J. Inorg. Chem. (Engl. Transl.), 1973, 18, 1273, (ir, salts)
• De Angelis, L., Drugs of Today (Barcelona), 1978, 14, 101, (rev, pharmacol)
• Barnett, B.L. et al., Acta Cryst. B, 1979, 35, 1212, (cryst struct)
• Motekaitis, R.J. et al., Inorg. Chem., 1980, 19, 1646, (props, complexes)
• Goeva, L.V., Radiokhimiya, 1982, 22, 591; Sov. Radiochem. (Engl. Transl.), 1982, 22, 489, (props)
• Afonin, E.G. et al., Zh. Obshch. Khim., 1987, 57, 538; 1989, 59, 317; J. Gen. Chem. USSR (Engl. Transl.), 1987, 57, 469; 1989, 59, 273, (acid, salts, ir)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 658
• Strates, B.S. et al., Biochim. Biophys. Acta, 1971, 244, 121, (pharmacol)
• Wiers, B.H., Inorg. Chem., 1971, 10, 2581, (salts)
• Van der Pol, H.J., Pharm. Weekbl., 1983, 118, 330, (anal, props)